2023-05-28 09:44:30
“It is an attempt at scuttling. » Valérie Verdier, President and CEO of the Research Institute for Development (IRD), one of the founding structures of the Mediterranean Infection University Hospital Institute (IHU), sighs at the mention of the study on the effectiveness of hydroxychloroquine, made public on April 4 by Professor Didier Raoult. Like Eric Berton, president of Aix-Marseille University (AMU), or François Crémieux, director general of the university hospitals of Marseille (AP-HM), other members of the board of directors of the IHU, she sees in the implementation online, in preprint, of this analysis co-signed by several senior executives of the institute a ” bad shot “. “This takes us one step back, at a time when we are all trying to restore the scientific legitimacy of the IHU”laments Eric Berton. “The context means that everything Didier Raoult says continues to be associated with the institute”notes, with regret, the boss of the AP-HM.
Nine months after his departure from the management of the Mediterranean Infection Foundation, parent structure of the IHU, and the decision of the National Medicines Safety Agency (ANSM) to prohibit all clinical research within the institute that he was piloting, following a first inspection in 2022, the retired Raoult is still within the walls. ” A plaster “, slips a researcher. Rather, a thorn, whose presence painfully stings those who hoped to see it fade quickly.
Wednesday, May 24, like almost every day, the silhouette of the media doctor and microbiologist rushes into the elevator of the IHU. The access code to the fourth floor, that of the management, has not changed. The only difference for him is that his office is no longer on the right, but on the left when leaving the elevator. “A table in a work room”would like to put Pierre-Edouard Fournier, who took over on 1is September 2022 and claims to have no control over the situation of his predecessor.
Emeritus professor thanks to the Grand Prize of the National Institute of Health and Medical Research (Inserm) obtained in 2010, Didier Raoult has, as such, access to the IHU whenever he wishes. And does not deprive himself of it, in order to follow the work of his last two doctoral students and to work, for the Japanese group Hitachi, on the adaptation of electron microscopes to microbiology. The provision of an office was not an obligation. But no one offered an alternative. And especially not the university, which does not want to be accused of extending the professor’s lease on one of its sites. “He is present, but his impact internally has become almost nil”convinces himself François Crémieux.
You have 69.5% of this article left to read. The following is for subscribers only.
#Marseille #IHU #poisonous #legacy #Didier #Raoult